Daniele Peroni

Daniele Peroni

Auto-generated profile, based on publicly available information

Daniele Peroni

Laboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Trento, Italy

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Experimental Cell Research
Verified
Journal Article
Closed access
RBRoberta Bonafede
Roberta Bonafede
ISIlaria Scambi
Ilaria Scambi
DPDaniele Peroni
Daniele Peroni
VPValentina Potrich
Valentina Potrich
FBFederico Boschi
Federico Boschi
RMRaffaella Mariotti
Raffaella Mariotti

12 November 2007 in Oncogene
Verified
Journal Article
Closed access
MGMirco Galiè
Mirco Galiè
Georgia KonstantinidouGeorgia Konstantinidou
Georgia Konstantinidou
DPD Peroni
D Peroni
ISI Scambi
I Scambi
CMC Marchini
C Marchini
AAA Amici
A Amici

1 February 2008 in Experimental Cell Research
Verified
Journal Article
Closed access
DPDaniele Peroni
Daniele Peroni
ISIlaria Scambi
Ilaria Scambi
APAnnalisa Pasini
Annalisa Pasini
VLVeronica Lisi
Veronica Lisi
Francesco BifariFrancesco Bifari
Francesco Bifari
MGMirco Galiè
Mirco Galiè

17 October 2019 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ECElisa Calabria
Elisa Calabria
ISIlaria Scambi
Ilaria Scambi
RBRoberta Bonafede
Roberta Bonafede
LSLorenzo Schiaffino
Lorenzo Schiaffino
DPDaniele Peroni
Daniele Peroni
RMRaffaella Mariotti
Raffaella Mariotti
The amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by motoneurons death. Mutations in the superoxide dismutase 1 (SOD1) protein have been identified to be related to the disease. Beyond the different altered pathways, the mitochondrial dysfunction is one of the major features that leads to the selective death of motoneurons in ALS. The NSC-34 cell line, overexpressing human SOD1(G93A) mutant protein [NSC-34(G93A)], is considered an optimal in vitro model to study ALS. Here we investigated the energy metabolism in NSC-34(G93A) cells and in particular the effect of the mutated SOD1(G93A) protein on the mitochondrial respiratory capacity (complexes I-IV) by high resolution respirometry (HRR) and cytofluorimetry. We demonstrated that NSC-34(G93A) cells show a reduced mitochondrial oxidative capacity. In particular, we found significant impairment of the complex I-linked oxidative phosphorylation, reduced efficiency of the electron transfer system (ETS) associated with a higher rate of dissipative respiration, and a lower membrane potential. In order to rescue the effect of the mutated SOD1 gene on mitochondria impairment, we evaluated the efficacy of the exosomes, isolated from adipose-derived stem cells, administrated on the NSC-34(G93A) cells. These data show that ASCs-exosomes are able to restore complex I activity, coupling efficiency and mitochondrial membrane potential. Our results improve the knowledge about mitochondrial bioenergetic defects directly associated with the SOD1(G93A) mutation, and prove the efficacy of adipose-derived stem cells exosomes to rescue the function of mitochondria, indicating that these vesicles could represent a valuable approach to target mitochondrial dysfunction in ALS.

29 January 2014 in Translation
Verified
Journal Article
Open access
PDF file
EDErik Dassi
Erik Dassi
ARAngela Re
Angela Re
SLSara Leo
Sara Leo
TTToma Tebaldi
Toma Tebaldi
LPLuigi Pasini
Luigi Pasini
AQAlessandro Quattrone
Alessandro Quattrone
Post-transcriptional regulation (PTR) of gene expression is now recognized as a major determinant of cell phenotypes. The recent availability of methods to map protein-RNA interactions in entire transcriptomes such as RIP, CLIP and their variants, together with global polysomal and ribosome profiling techniques, are driving the exponential accumulation of vast amounts of data on mRNA contacts in cells, and of corresponding predictions of PTR events. However, this exceptional quantity of information cannot be exploited at its best to reconstruct potential PTR networks, as it still lies scattered throughout several databases and in isolated reports of single interactions. To address this issue, we developed the second and vastly enhanced version of the Atlas of UTR Regulatory Activity (AURA 2), a meta-database centered on mapping interaction of trans-factors with human and mouse UTRs. AURA 2 includes experimentally demonstrated binding sites for RBPs, ncRNAs, thousands of cis-elements, variations, RNA epigenetics data and more. Its user-friendly interface offers various data-mining features including co-regulation search, network generation and regulatory enrichment testing. Gene expression profiles for many tissues and cell lines can be also combined with these analyses to display only the interactions possible in the system under study. AURA 2 aims at becoming a valuable toolbox for PTR studies and at tracing the road for how PTR network-building tools should be designed. AURA 2 is available at http://aura.science.unitn.it.

1 July 2018 in Molecular Cell
Verified
Journal Article
Open access
TTToma Tebaldi
Toma Tebaldi
PZPaola Zuccotti
Paola Zuccotti
DPDaniele Peroni
Daniele Peroni
MKMarcel Köhn
Marcel Köhn
LGLisa Gasperini
Lisa Gasperini
AQAlessandro Quattrone
Alessandro Quattrone
The RNA-binding protein HuD promotes neurogenesis and favors recovery from peripheral axon injury. HuD interacts with many mRNAs, altering both stability and translation efficiency. We generated a nucleotide resolution map of the HuD RNA interactome in motor neuron-like cells, identifying HuD target sites in 1,304 mRNAs, almost exclusively in the 3' UTR. HuD binds many mRNAs encoding mTORC1-responsive ribosomal proteins and translation factors. Altered HuD expression correlates with the translation efficiency of these mRNAs and overall protein synthesis, in a mTORC1-independent fashion. The predominant HuD target is the abundant, small non-coding RNA Y3, amounting to 70% of the HuD interaction signal. Y3 functions as a molecular sponge for HuD, dynamically limiting its recruitment to polysomes and its activity as a translation and neuron differentiation enhancer. These findings uncover an alternative route to the mTORC1 pathway for translational control in motor neurons that is tunable by a small non-coding RNA.